Market Overview

A Peek Into The Market Before The Trading Starts

A Peek Into The Market Before The Trading Starts
Related AMGN
Are There Any Winners Left In The Biotech Space?
Is Illumina Worth Adding To Your Portfolio?
The Tech Industry is Vanishing Before Our Eyes (Fox Business)

Pre-open movers US stock futures are mixed this morning, as investors are awaiting economic data. Futures for the Dow Jones Industrial Average dropped 14 points to 13,561.00 and S&P 500 index futures fell 0.80 points to 1,478.10. Nasdaq 100 futures surged 2.25 points to 2,736.00.

A Peek Into Global Markets European markets were lower today. The STOXX Europe 600 Index fell 0.15%, London's FTSE 100 Index dropped 0.11%, German DAX 30 Index dropped 0.41% and French CAC 40 Index fell 0.26%.

Asian markets ended mostly lower, with Japan's Nikkei Stock Average falling 0.35%, China's Shanghai Composite dropping 0.56% and Australia's S&P/ASX 200 Index climbing 0.01%. Hong Kong's Hang Seng Index gained 0.29% and India's Sensex declined 0.60%.

Broker Recommendation Analysts at Credit Suisse downgraded Amgen (NASDAQ: AMGN) from “outperform” to “neutral.” The target price for Amgen has been lowered from $100 to $90.

Amgen shares fell 1.05% to $81.22 in pre-market trading.

Breaking news

  • Chuy's Holdings (NASDAQ: CHUY) announced today that it has commenced a proposed secondary public offering of 4,500,000 shares of common stock. To read the full news, click here.
  • DuPont Co (NYSE: DD) reported a 70% drop in its fourth-quarter earnings. To read the full news, click here.
  • Baidu (NASDAQ: BIDU) announced today that its Personal Cloud Service (PCS), which includes NetDrive, reached the 30 million registered user mark on January 18. To read the full news, click here.
  • Ampio Pharmaceuticals (NASDAQ: AMPE) announced today that the FDA has accepted the Company's IND for Optina™ for the treatment of diabetic macular edema (DME). To read the full news, click here.

Posted-In: Credit Suisse US Stock FuturesNews Futures Global Pre-Market Outlook Markets

 

Related Articles (AMGN + AMPE)

Around the Web, We're Loving...

Get Benzinga's Newsletters